Cumberland PharmaceuticalsCPIX
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 33 institutions reported holding Cumberland Pharmaceuticals (CPIX) in their 13F filings, up 13 from Q4 2024. 14 opened new positions and 1 sold out. The largest holders were Millennium Management ($3.4M), Ikarian Capital, LLC ($3.1M) and Renaissance Technologies ($2.1M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cumberland Pharmaceuticals
- CUSIP
- 230770109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $10.9M |
| Exits | 1 | $5K |
All 13F filers, Q4 2024 → Q1 2025: 2,636,532 shares bought and 198,556 shares sold, net +2,437,976 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Millennium Management | 0.00% | New | 809,897 | $3.4M |
| Ikarian Capital, LLC | 1.02% | New | 740,000 | $3.1M |
| Renaissance Technologies | 0.00% | Reduce -0.8% | 503,363 | $2.1M |
| Vanguard Group Inc. | 0.00% | Add +11.3% | 416,569 | $1.8M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -7.6% | 252,189 | $1.1M |
| J. Goldman & Co LP | 0.04% | New | 241,481 | $1.0M |
| Boothbay Fund Management, LLC | 0.03% | New | 223,798 | $947K |
| Bridgeway Capital Management, LLC | 0.02% | No change | 184,155 | $779K |
| Berkshire Asset Management LLC | 0.03% | New | 153,810 | $692K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 150,000 | $635K |
| Geode Capital Management, LLC | 0.00% | Add +33.4% | 99,091 | $419K |
| Bank of New York Mellon Corp | 0.00% | Reduce -3.7% | 72,513 | $307K |
| Informed Momentum Co LLC | 0.05% | New | 71,776 | $304K |
| Walleye Capital LLC | 0.00% | New | 70,419 | $298K |
| Acadian Asset Management LLC | 0.00% | Reduce -73.9% | 49,137 | $207K |
| State Street Corp. | 0.00% | No change | 33,700 | $143K |
| BlackRock, Inc. | 0.00% | Reduce -23.3% | 32,658 | $138K |
| Susquehanna International Group, LLP | 0.00% | New | 28,939 | $122K |
| Citadel Advisors | 0.00% | New | 25,814 | $109K |
| Two Sigma Investments, LP | 0.00% | Reduce -39.6% | 22,755 | $96K |
| Cresset Asset Management, LLC | 0.00% | Reduce -10.3% | 19,975 | $84K |
| Northern Trust Corp. | 0.00% | Add +24.8% | 19,603 | $83K |
| Simplex Trading, LLC | 0.00% | New | 19,100 | $80K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 17,900 | $76K |
| &partners | 0.00% | New | 11,000 | $49K |
| UBS Group AG | 0.00% | Reduce -34.9% | 5,337 | $23K |
| Morgan Stanley | 0.00% | No change | 2,660 | $11K |
| Centiva Capital, LP | 0.00% | New | 1,600 | $7K |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 437 | $2K |
| Wells Fargo & Company | 0.00% | No change | 250 | $1K |
| Bank of America Corp. | 0.00% | Add +4.6% | 68 | $288 |
| JPMorgan Chase & Co. | 0.00% | No change | 19 | $80 |
| Huntington National Bank | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is CPIX's weight in each manager's 13F, not the share of Cumberland Pharmaceuticals the manager owns.